Oestrogen/growth factor cross-talk in breast carcinoma: a specific target for novel antioestrogens

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.18, Iss.7, 1997-07, pp. : 245-251

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective oestrogen receptor modulators, pure antioestrogens and related oestrogen receptor ligands

By Redden Peter R

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 3, 2004-03 ,pp. : 337-353

Informa Healthcare

Access to resources Recommend Favorite

Evidence for receptor subtype cross-talk in the mitogenic action of serotonin on human small-cell lung carcinoma cells

By Vicentini L.M. Cattaneo M.G. Fesce R.

European Journal of Pharmacology, Vol. 318, Iss. 2, 1996-12 ,pp. : 497-504

Elsevier

Access to resources Recommend Favorite

Evidence for cross-talk between stanniocalcins

By Paciga Mark James Kathi Gillespie J Ryan J Wagner Graham F

Canadian Journal of Physiology and Pharmacology, Vol. 83, Iss. 11, 2005-11 ,pp. : 953-956

NRC Research Press

Access to resources Recommend Favorite

Oestrogen and nerve growth factor – neuroprotection and repair in Alzheimer’s disease

By Granholm A-C.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. : 685-694

Informa Healthcare

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor (EGFR) and its Cross-Talks with Topoisomerases: Challenges and Opportunities for Multi-Target Anticancer Drugs

Current Pharmaceutical Design, Vol. 22, Iss. 21, 2016-06 ,pp. : 3226-3236

Bentham Science Publishers

Access to resources Recommend Favorite